IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 47 filers reported holding IKENA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,930 | +25.8% | 29,776 | +90.6% | 0.00% | – |
| Q2 2023 | $102,487 | +331.7% | 15,623 | +127.0% | 0.00% | – |
| Q1 2023 | $23,743 | -2.0% | 6,882 | -24.4% | 0.00% | – |
| Q4 2022 | $24,230 | +1111.5% | 9,109 | +1376.3% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 617 | +100.3% | 0.00% | – |
| Q2 2022 | $1,000 | -98.7% | 308 | -97.5% | 0.00% | – |
| Q1 2022 | $75,000 | -75.7% | 12,424 | -49.6% | 0.00% | – |
| Q4 2021 | $309,000 | +123.9% | 24,642 | +125.6% | 0.00% | – |
| Q3 2021 | $138,000 | +130.0% | 10,922 | +154.1% | 0.00% | – |
| Q2 2021 | $60,000 | – | 4,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |